Contact: Bill Schaller
Dana-Farber Cancer Institute
Caption: Wolfram Goessling, M.D., Ph.D., and colleagues demonstrated that an innovative experimental treatment for boosting the effectiveness of stem-cell transplants with umbilical cord blood has a favorable safety profile in long-term animal studies.
Credit: Sam Ogden
Usage Restrictions: None
Related news release: Enhanced cord blood stem cell transplants safe in long-term studies